93 related articles for article (PubMed ID: 7619738)
1. Syncytium forming capacity of HIV 1 strains in inhibited by pretreatment of CD4 expressing cells with 3'-azido-3'-deoxythymidine but not by alpha interferon.
Ruţă SM; Cernescu C
Rev Roum Virol; 1994; 45(3-4):171-83. PubMed ID: 7619738
[TBL] [Abstract][Full Text] [Related]
2. 3'-Azido-3'-deoxythymidine-induced reduction in the ability of uninfected CD4-expressing cells to participate in syncytium formation.
Buckheit RW; Germany-Decker J; Qualls-Goodwin K; Bowdon BJ; Shannon WM
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8361-5. PubMed ID: 1355606
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro.
Yang JY; Schwartz A; Henderson EE
Biochem Biophys Res Commun; 1994 Jun; 201(3):1424-32. PubMed ID: 8024587
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
[TBL] [Abstract][Full Text] [Related]
5. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Düzgünes N
Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania.
Easterbrook MD; Levy MH; Gomez AM; Turco SJ; Epand RM; Rosenthal KL
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):496-505. PubMed ID: 8548328
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice.
Prakash O; Rodriguez VE; Tang ZY; Zhou P; Coleman R; Dhillon G; Shellito JE; Nelson S
Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858
[TBL] [Abstract][Full Text] [Related]
9. The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells.
Vanham G; van Tendeloo V; Willems B; Penne L; Kestens L; Beirnaert E; Fransen K; Heyndrickx L; Zhong P; Davis D; Berneman Z; van Der Groen G; Van Bockstaele D
J Med Virol; 2000 Mar; 60(3):300-12. PubMed ID: 10630963
[TBL] [Abstract][Full Text] [Related]
10. Syncytium formation amplifies apoptotic signals: a new view on apoptosis in HIV infection in vitro.
Scheller C; Jassoy C
Virology; 2001 Mar; 282(1):48-55. PubMed ID: 11259189
[TBL] [Abstract][Full Text] [Related]
11. Amino functionalized novel cholic acid derivatives induce HIV-1 replication and syncytia formation in T cells.
Salunke DB; Ravi DS; Pore VS; Mitra D; Hazra BG
J Med Chem; 2006 Apr; 49(8):2652-5. PubMed ID: 16610808
[TBL] [Abstract][Full Text] [Related]
12. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.
Agy MB; Acker RL; Sherbert CH; Katze MG
Virology; 1995 Dec; 214(2):379-86. PubMed ID: 8553538
[TBL] [Abstract][Full Text] [Related]
13. Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo.
Fouchier RA; Meyaard L; Brouwer M; Hovenkamp E; Schuitemaker H
Virology; 1996 May; 219(1):87-95. PubMed ID: 8623557
[TBL] [Abstract][Full Text] [Related]
14. Transmission of HIV-1 from productively infected mature Langerhans cells to primary CD4+ T lymphocytes results in altered T cell responses with enhanced production of IFN-gamma and IL-10.
Ludewig B; Gelderblom HR; Becker Y; Schäfer A; Pauli G
Virology; 1996 Jan; 215(1):51-60. PubMed ID: 8553586
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-HIV activity of steroidal prodrugs of 3'-azido-3'-deoxythymidine (AZT).
Balagopala MI; Ollapally AP; Lee HJ
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S1-7. PubMed ID: 8574137
[TBL] [Abstract][Full Text] [Related]
16. Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine.
Gao WY; Johns DG; Tanaka M; Mitsuya H
Mol Pharmacol; 1999 Mar; 55(3):535-40. PubMed ID: 10051538
[TBL] [Abstract][Full Text] [Related]
17. Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain (gp41) of the human immunodeficiency virus type 1 envelope.
Sabatier JM; Mabrouk K; Moulard M; Rochat H; Van Rietschoten J; Fenouillet E
Virology; 1996 Sep; 223(2):406-8. PubMed ID: 8806580
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV-1 activity of enfuvirtide (T-20) by inhibition of bystander cell death.
Barretina J; Blanco J; Armand-Ugón M; Gutiérrez A; Clotet B; Esté JA
Antivir Ther; 2003 Apr; 8(2):155-61. PubMed ID: 12741628
[TBL] [Abstract][Full Text] [Related]
19. HIV-induced syncytia in peripheral blood cell cultures crawl by extending giant pseudopods.
Shutt DC; Stapleton JT; Kennedy RC; Soll DR
Cell Immunol; 1995 Dec; 166(2):261-74. PubMed ID: 7497528
[TBL] [Abstract][Full Text] [Related]
20. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
